EE423 Cost-Effectiveness of Vaccinating Adults ≥65 Years and at-Risk Individuals 18-64 Years With the 20-Valent Pneumococcal Conjugate Vaccine Versus Currently Recommended Vaccine Regimens in Sweden
Abstract
Authors
AC Dorange A Palmborg R Sato M Atwood